Biosig awarded u.s. patent claims for the noise-filtering methods for its signal processing technology

Westport, ct, march 30, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that the u.s. patent office had allowed a utility patent covering its pure ep™ noise-filtering technology. the recently allowed patent application number 17/082,564 entitled “systems and methods for performing electrophysiology (ep) signal processing " was filed on october 28, 2020. the patent describes and claims systems and methods for filtering noise (e.g., a cardiac signal) during a quiet period. in particular, this patent involves filtering out harmonics and noise from an input cardiac signal.
BSGM Ratings Summary
BSGM Quant Ranking